Bridgeway Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57,500
Closed -$67.8K 1310
2025
Q4
$67.8K Hold
57,500
﹤0.01% 1165
2025
Q3
$85.7K Hold
57,500
﹤0.01% 1125
2025
Q2
$112K Hold
57,500
﹤0.01% 1052
2025
Q1
$70.2K Buy
57,500
+6,800
+13% +$16.7K ﹤0.01% 1093
2024
Q4
$153K Sell
50,700
-52,300
-51% -$147K ﹤0.01% 1055
2024
Q3
$261K Buy
103,000
+50,000
+94% +$178K 0.01% 1006
2024
Q2
$249K Buy
53,000
+16,000
+43% +$84.3K 0.01% 1005
2024
Q1
$210K Sell
37,000
-42,000
-53% -$277K ﹤0.01% 1102
2023
Q4
$523K Buy
79,000
+20,000
+34% +$116K 0.01% 929
2023
Q3
$472K Hold
59,000
0.01% 893
2023
Q2
$598K Hold
59,000
0.01% 857
2023
Q1
$628K Hold
59,000
0.02% 830
2022
Q4
$679K Hold
59,000
0.02% 821
2022
Q3
$503K Sell
59,000
-18,000
-23% -$149K 0.01% 895
2022
Q2
$547K Buy
77,000
+15,000
+24% +$125K 0.01% 861
2022
Q1
$721K Hold
62,000
0.01% 857
2021
Q4
$794K Hold
62,000
0.01% 837
2021
Q3
$847K Sell
62,000
-25,000
-29% -$349K 0.02% 870
2021
Q2
$1.4M Buy
87,000
+41,300
+90% +$566K 0.03% 741
2021
Q1
$681K Buy
+45,700
New +$688K 0.01% 1009
2020
Q3
Sell
-18,700
Closed -$242K 1357
2020
Q2
$242K Buy
18,700
+8,700
+87% +$114K ﹤0.01% 1099
2020
Q1
$78K Buy
+10,000
New +$135K ﹤0.01% 1199

Other funds holding TELA

Bridgeway Capital Management's TELA Position: Q1 2026 in Review

Bridgeway Capital Management sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 57,500 shares — an estimated $67.8K sold.

Bridgeway Capital Management first reported a position in TELA in Q1 2020 and held it in 22 quarters. The position peaked at $1.4M in Q2 2021. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Bridgeway Capital Management reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 57,500 TELA Bio shares in Q1 2026, an estimated $67.8K.
  • Bridgeway Capital Management first reported a position in TELA Bio in Q1 2020 and held it in 22 quarters.
  • Bridgeway Capital Management's TELA Bio position peaked at $1.4M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.